IL-6: Difference between revisions
CSV import |
No edit summary Tag: Manual revert |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 30: | Line 30: | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
Latest revision as of 12:49, 18 March 2025
IL-6 or Interleukin 6 is a cytokine protein that plays an important role in immune response. It is a significant factor in the reactions of the immune system during infection and after trauma, especially burns or other tissue damage leading to inflammation.
Function[edit]
IL-6 is secreted by T cells and macrophages to stimulate immune response, especially during tissue damage and infection. It is capable of crossing the blood-brain barrier and initiating synthesis of C-reactive protein and fibrinogen by the liver.
Clinical Significance[edit]
Elevated levels of IL-6 have been linked to a number of clinical conditions including rheumatoid arthritis, systemic lupus erythematosus, and cancer. It is also implicated in the pathophysiology of depression and Alzheimer's disease.
Therapeutic Use[edit]
Several drugs have been developed that target IL-6 or its receptor. These include tocilizumab, sarilumab, and siltuximab, which are used in the treatment of rheumatoid arthritis and other inflammatory conditions.


